Back to 
Northern Trust Corp.
Northern Trust Corp.
RNAC
9 quarters
Position history for Northern Trust Corp.'s holdings in Cartesian Therapeutics, Inc.
Yes. Northern Trust holds 105,698 shares of RNAC (Cartesian Therapeutics), worth $1.1M, as of its Q2 2026 13F filing. It increased the position by 13,706 shares (+14.9%) from Q1 2026. Northern Trust has held RNAC in every 13F on record since Q2 2024, 9 quarterly filings.
Current Value
$1.1M
Current Shares
105,698
Total Value Change
+$266,116
Total Shares Change
+74,774
Quarter-by-Quarter History
Other major holders of RNAC: FMR LLC, Squarepoint Ops LLC